Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
In a recent multi‐family study of autoimmune disorders, DGKD (HGNC:2851) was flagged as a candidate gene for rheumatoid arthritis (PMID:31848144). The study, which applied whole‑exome sequencing in 31 families, identified DGKD among several T cell receptor signalling pathway genes with rare variants present across affected relatives. However, specific DGKD variants were not robustly reported, and the number of probands carrying pathogenic changes in DGKD remains limited (PMID:31848144).
Complementary functional assessment studies have characterized alternative splicing events in DGKD that affect its regulatory functions and subcellular localization (PMID:12200442). These experiments, performed in the context of neoplasms rather than rheumatoid arthritis, do not directly corroborate a role in arthritis pathogenesis. Overall, the genetic screening data combined with the indirect functional insights yield a limited yet suggestive association between DGKD and rheumatoid arthritis. Key take‑home: Additional targeted studies are necessary to ascertain DGKD’s pathogenic contribution to rheumatoid arthritis and enhance its clinical utility in diagnostic decision‑making.
Gene–Disease AssociationLimitedDGKD was identified in a multi‐family study of autoimmune phenotypes involving rheumatoid arthritis (PMID:31848144), but the lack of robust proband‐specific data limits the strength of its association. Genetic EvidenceLimitedThe gene appeared in gene‐set analyses of 31 families with autoimmune disorders, yet no specific pathogenic coding variants in DGKD were reported, restricting the overall genetic evidence (PMID:31848144). Functional EvidenceLimitedFunctional studies demonstrate alternative splicing effects on DGKD protein function in a neoplastic setting (PMID:12200442), which does not directly validate its role in rheumatoid arthritis. |